Georgia Anguera

6PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCellular immunologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Pembrolizumab-Associated Polyserositis with Eosinophilic Pleural Effusion During Adjuvant Therapy for Clear Cell Renal Cell Carcinoma: A Case Report and Targeted Review.

|Mar 28, 2026
<i>TFE3</i>-Rearranged and <i>TFEB</i>-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances.

Mikel Portu, Mario Balsa, Maria Cotaina

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|May 25, 2024
Potential Role of Circulating PD-L1<sup>+</sup> Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients.

Georgia Anguera, Maria Mulet, Carlos Zamora

|May 11, 2024
Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors.

Leticia Alserawan, Maria Mulet, Geòrgia Anguera

|May 09, 2024
Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution.

Javier Gavira, Jose Carlos Tapia, Alejandra Romano

Pageof 1

Frequent Collaborators

2 joint publications

Maria Mulet

2 joint publications

Rubén Osuna-Gómez

2 joint publications

Ivana Sullivan

2 joint publications

Margarita Majem